Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020.

Journal of medical microbiology - 1 Dec 2021

Ramstad Silje N, Brandal Lin T, Taxt Arne M, Wasteson Yngvild, Bjørnholt Jørgen V, Naseer Umaer

Abstract excerpt

Introduction. Shiga toxin-producing Escherichia coli (STEC) can cause severe to fatal disease in humans. Antimicrobial treatment is sometimes necessary, but contraindicated due to undesirable clinical outcome. However, recent studies have shown promising outcomes following antimicrobial treatment. Before the establishment of a possible antimicrobial treatment strategy for STEC infections, the prevalence of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Multilocus Sequence Typing

Share to Norway

Share to Phylogeny

Share to Prevalence

Share to Shiga-Toxigenic Escherichia coli

Source

Open in PubMed Open full text

Identifiers

PMID: 34870582
DOI: 10.1099/jmm.0.001454
PMCID: PMC8744279

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020.PMID 34870582Read ↗

Antibiotic‐resistant Shiga toxin‐producing Escherichia coli: An overview of prevalence and intervention strategiesSemantic proximity Read ↗

Genotypic analysis of Shiga toxin-producing Escherichia coli clonal complex 17 in England and Wales, 2014-2022.Semantic proximity Read ↗

Antimicrobial resistance in Shiga toxin-producing Escherichia coli other than serotype O157 : H7 in England, 2014-2016.Semantic proximity Read ↗

Virulence Characteristics and Antibiotic Resistance Profiles of Shiga Toxin-Producing Escherichia coli Isolates from Diverse SourcesSemantic proximity Read ↗

Prevalence, Antimicrobial Resistance, and Whole Genome Sequencing Analysis of Shiga Toxin-Producing Escherichia coli (STEC) and Enteropathogenic Escherichia coli (EPEC) from Imported Foods in China during 2015–2021Semantic proximity Read ↗

Isolation, genotyping and antimicrobial resistance of Shiga toxin-producing Escherichia coli.Semantic proximity Read ↗

Genomic features and antimicrobial resistance patterns of Shiga toxin‐producing Escherichia coli strains isolated from food in ChileSemantic proximity Read ↗

Virulence gene profiles and phylogeny of Shiga toxin-positive Escherichia coli strains isolated from FDA regulated foods during 2010-2017Semantic proximity Read ↗

Outbreak of Shiga Toxin–Producing Escherichia coli (STEC) O104:H4 Infection in Germany Causes a Paradigm Shift with Regard to Human Pathogenicity of STEC StrainsSemantic proximity Read ↗

Virulence gene profiles and phylogeny of Shiga toxin-positive <i>Escherichia coli</i> strains isolated from FDA regulated foods during 2010-2017Semantic proximity Read ↗

Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing Escherichia coli Isolates from Humans in South Africa: 2006–2013Semantic proximity Read ↗

Integrated genomic and phenotypic characterization of antimicrobial resistance in Shiga toxin-producing Escherichia coli from asymptomatic carriers in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.